Quantifying the Clinical Significance of Cannabis Withdrawal

Background and Aims Questions over the clinical significance of cannabis withdrawal have hindered its inclusion as a discrete cannabis induced psychiatric condition in the Diagnostic and Statistical Manual of Mental Disorders (DSM IV). This study aims to quantify functional impairment to normal daily activities from cannabis withdrawal, and looks at the factors predicting functional impairment. In addition the study tests the influence of functional impairment from cannabis withdrawal on cannabis use during and after an abstinence attempt. Methods and Results A volunteer sample of 49 non-treatment seeking cannabis users who met DSM-IV criteria for dependence provided daily withdrawal-related functional impairment scores during a one-week baseline phase and two weeks of monitored abstinence from cannabis with a one month follow up. Functional impairment from withdrawal symptoms was strongly associated with symptom severity (p = 0.0001). Participants with more severe cannabis dependence before the abstinence attempt reported greater functional impairment from cannabis withdrawal (p = 0.03). Relapse to cannabis use during the abstinence period was associated with greater functional impairment from a subset of withdrawal symptoms in high dependence users. Higher levels of functional impairment during the abstinence attempt predicted higher levels of cannabis use at one month follow up (p = 0.001). Conclusions Cannabis withdrawal is clinically significant because it is associated with functional impairment to normal daily activities, as well as relapse to cannabis use. Sample size in the relapse group was small and the use of a non-treatment seeking population requires findings to be replicated in clinical samples. Tailoring treatments to target withdrawal symptoms contributing to functional impairment during a quit attempt may improve treatment outcomes.

[1]  Frank E. Harrell,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2001 .

[2]  J. Hughes,et al.  Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse. , 2008, Journal of substance abuse treatment.

[3]  B Powis,et al.  The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. , 1995, Addiction.

[4]  H. Akaike.  A new look at the statistical model identification , 1974 .

[5]  T. Schuster,et al.  Risk assessment of moderate to severe alcohol withdrawal--predictors for seizures and delirium tremens in the course of withdrawal. , 2011, Alcohol and alcoholism.

[6]  W. Hall,et al.  Are detoxification programmes effective? , 1996, The Lancet.

[7]  A. Budney,et al.  The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress. , 2011, Drug and alcohol dependence.

[8]  C. Stanger,et al.  Cannabis withdrawal in adolescent treatment seekers. , 2005, Drug and alcohol dependence.

[9]  Linda C. Sobell,et al.  Alcohol Timeline Followback 1979 , 1995 .

[10]  S. Vosburg,et al.  Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse , 2008, Psychopharmacology.

[11]  M. Farrell,et al.  Opiate withdrawal : Withdrawal syndrome , 1994 .

[12]  J. Copeland,et al.  Clinical profile of participants in a brief intervention program for cannabis use disorder. , 2001, Journal of substance abuse treatment.

[13]  S. Gilmour,et al.  The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut-off. , 2006, Drug and alcohol dependence.

[14]  T. Crowley,et al.  Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders. , 1998, Drug and alcohol dependence.

[15]  B. Grant,et al.  Cannabis withdrawal in the United States: results from NESARC. , 2008, The Journal of clinical psychiatry.

[16]  O. Aasland,et al.  Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. , 1993, Addiction.

[17]  S. Fu,et al.  Novel automated extraction method for quantitative analysis of urinary 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid (THC-COOH). , 2008, Journal of Analytical Toxicology.

[18]  J. Hughes,et al.  Marijuana abstinence effects in marijuana smokers maintained in their home environment. , 2001, Archives of general psychiatry.

[19]  Timothy B Baker,et al.  Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations. , 2003, Journal of abnormal psychology.

[20]  M Farrell,et al.  Opiate withdrawal. , 1994, Addiction.

[21]  M. Schuckit,et al.  The DSM-IV field trial for substance use disorders: major results. , 1995, Drug and alcohol dependence.

[22]  B Powis,et al.  Severity of dependence and route of administration of heroin, cocaine and amphetamines. , 1992, British journal of addiction.

[23]  E. Steyerberg,et al.  [Regression modeling strategies]. , 2011, Revista espanola de cardiologia.

[24]  S. Heishman,et al.  Cannabis withdrawal among non-treatment-seeking adult cannabis users. , 2006, The American journal on addictions.

[25]  W. Hall,et al.  The alcohol withdrawal syndrome , 1997, The Lancet.

[26]  J. Zimmermann,et al.  Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients. , 2010, Drug and alcohol dependence.

[27]  John P. Allen,et al.  The alcohol use disorders identification test: an update of research findings. , 2007, Alcoholism, clinical and experimental research.

[28]  L. Magee,et al.  R 2 Measures Based on Wald and Likelihood Ratio Joint Significance Tests , 1990 .

[29]  A. Broocks,et al.  The reliability and validity of the Alcohol Use Disorders Identification Test (AUDIT) in a German general practice population sample. , 2006, Journal of studies on alcohol.

[30]  H. Kraemer,et al.  Caution regarding the use of pilot studies to guide power calculations for study proposals. , 2006, Archives of general psychiatry.

[31]  D. Hatsukami,et al.  Signs and symptoms of tobacco withdrawal. , 1986, Archives of general psychiatry.

[32]  Patrick Royston,et al.  The cost of dichotomising continuous variables , 2006, BMJ : British Medical Journal.

[33]  R. Friedman,et al.  Automated telephone screening for problem drinking. , 2006, Journal of studies on alcohol.

[34]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[35]  J. Coyne,et al.  Older primary care patients' willingness to consider discontinuation of chronic benzodiazepines. , 2007, General hospital psychiatry.

[36]  D. W. Zimmerman,et al.  Relative Power of the Wilcoxon Test, the Friedman Test, and Repeated-Measures ANOVA on Ranks , 1993 .

[37]  J. Rehm,et al.  Incorporating the AUDIT into a general population telephone survey: a methodological experiment. , 2000, Drug and alcohol dependence.

[38]  D. Kelly,et al.  Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers. , 2010, Drug and alcohol dependence.

[39]  M. Haney.  The marijuana withdrawal syndrome: Diagnosis and treatment , 2005, Current psychiatry reports.

[40]  J. Copeland,et al.  Randomized controlled trial of a novel cannabis use intervention delivered by telephone. , 2012, Addiction.

[41]  Linda C. Sobell,et al.  Alcohol Timeline Followback , 2000 .

[42]  A. Agrawal,et al.  Is there evidence for symptoms of cannabis withdrawal in the national epidemiologic survey of alcohol and related conditions? , 2008, The American journal on addictions.

[43]  D. Kelly,et al.  Diagnostic criteria for cannabis withdrawal syndrome. , 2012, Drug and alcohol dependence.

[44]  D. Clark,et al.  Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence. , 2008, Addictive behaviors.

[45]  L. Kraus,et al.  The validity of DSM-IV cannabis abuse and dependence criteria in adolescents and the value of additional cannabis use indicators. , 2011, Addiction.

[46]  F. Musshoff,et al.  Review of Biologic Matrices (Urine, Blood, Hair) as Indicators of Recent or Ongoing Cannabis Use , 2006, Therapeutic drug monitoring.

[47]  J. Copeland,et al.  Quantifying cannabis use with the timeline followback approach: a psychometric evaluation. , 2012, Drug and alcohol dependence.

[48]  J. Hughes,et al.  The cannabis withdrawal syndrome , 2006, Current opinion in psychiatry.

[49]  J. Hughes,et al.  A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances. , 2008, Drug and alcohol dependence.